Avidity Biosciences, Inc.
NASDAQ:RNA
Overview | Financials
| Company Name | Avidity Biosciences, Inc. |
| Symbol | RNA |
| Currency | USD |
| Price | 48.05 |
| Market Cap | 6,181,776,554 |
| Dividend Yield | 0% |
| 52-week-range | 21.51 - 56 |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Ms. Sarah Boyce |
| Website | https://www.aviditybiosciences.com |
An error occurred while fetching data.
About Avidity Biosciences, Inc.
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic muscle
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD








